Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.140\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COc1ccc2[nH]c3c(C)c4ccncc4c(C)c3c2c1
b.) CCn1c(C)nc2cc(C(=O)NNC(=S)NC(=O)c3ccc(OC)cc3)ccc21
c.) CCCCOC(=S)NC(=O)c1sc2ccccc2c1Cl
d.) CC1CCN(S(=O)(=O)c2ccc3[nH]c(=O)cc(C(=O)O)c3c2)CC1
e.) CC(C)(C)c1ccc(OCCNC(=S)NC(=O)c2cccnc2)cc1
Answer: b. CCn1c(C)nc2cc(C(=O)NNC(=S)NC(=O)c3ccc(OC)cc3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(C)nc2cc(C(=O)NNC(=S)NC(=O)c3ccc(OC)cc3)ccc21
CCn1c(C)nc2cc(C(=O)NNC(=S)NC(=O)c3ccc(OC)cc3)ccc21
[C][C][N][C][Branch1][C][C][=N][C][=C][C][Branch2][Ring1][N][C][=Branch1][C][=O][N][N][C][=Branch1][C][=S][N][C][=Branch1][C][=O][C][=C][C][=C][Branch1][Ring1][O][C][C][=C][Ring1][Branch2][=C][C][=C][Ring2][Ring1][#Branch1][Ring2][Ring1][O]
N-[[(1-ethyl-2-methylbenzimidazole-5-carbonyl)amino]carbamothioyl]-4-methoxybenzamide